HDACs play a key role in regulating gene expression by changing chromatin structure, and V Novotny-Diermayr have demonstrated that the pan-HDACs inhibitor SB939 could inhibit the expression of FLT3 in AML cells [43]. This evidence concerns the gene FLT3 and acute myeloid leukemia.